UNI MEDICAL (02666) has announced that the following changes will take effect from March 25, 2026: (1) Mr. Wang Wenbing has resigned from his positions as Executive Director, Chief Executive Officer, and member of the Risk Control Committee due to other work commitments; and (2) Mr. Xia Qi has been appointed as Executive Director, Chief Executive Officer, and a member of the Risk Control Committee.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments